Dr Erin Michelle Moniz, | |
8700 Beverly Blvd Ste 7215, West Hollywood, CA 90048-1804 | |
(310) 423-6280 | |
Not Available |
Full Name | Dr Erin Michelle Moniz |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 8700 Beverly Blvd Ste 7215, West Hollywood, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154819514 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 29977 (California) | Secondary |
103G00000X | Clinical Neuropsychologist | PSY29977 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Erin Michelle Moniz, 8700 Beverly Blvd Ste 7215, West Hollywood, CA 90048-1804 Ph: (310) 423-6280 | Dr Erin Michelle Moniz, 8700 Beverly Blvd Ste 7215, West Hollywood, CA 90048-1804 Ph: (310) 423-6280 |
News Archive
Almost 12% of all adults in Germany are diagnosed with depression at some point in their lives. The German Institute for Quality and Efficiency in Health Care investigated whether participants in a screening programme could have advantages or disadvantages if their general practitioner, for example, offers regular tests based on a questionnaire that can reveal signs of depression.
Innovaro, a comprehensive innovation solutions company, is pleased to announce that it has facilitated the completion of a licensing transaction between Trojan Technologies USA, a company recently formed by Verdant Ventures Advisors II, LLC, and Trojantec Ltd, a London and Cyprus based biopharmaceutical company.
A new understanding of an enzyme important for the transfer of genetic information in bacteria may help scientists improve current antibiotics and also create antibiotics that are less vulnerable to resistance.
Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, according to a new study by NYU Langone Medicine Center researchers. The study is published online this week in the journal Nature.
For an innovative treatment, which allows to selectively direct nanoparticles of iron oxide into cell targets in the blood to fight chronic inflammatory disorders or cancer that was successfully tested in a cell culture and animal models, Dr. Andrea de Vizcaya Ruiz, was awarded with the Innovation Award in Bionanotechnology Cinvestav-Neolpharma 2015.
› Verified 1 days ago